Fundz

Oxford Cancer Analytics raised $11M in a Series A funding led by We Venture Capital and Cross-Border Impact Ventures to develop and globally commercialize liquid biopsy blood tests for early lung cancer detection.

PRIVATEJan 09, 2025

Amount Raised

$11 Million

Round Type

Series A

OxfordBiotechnologyHealth CareArtificial IntelligenceHealth Diagnostics

Investors

Aurelium VenturesDigitalDx VenturesWe Venture CapitalOkg CapitalMacmillan Cancer SupportCivilization VenturesEka VenturesCross Border Impact Ventures

Description

Oxford Cancer Analytics announced it has raised $11 million in Series A funding from global investors to advance its blood tests for early cancer detection. The funding will help the company commercialize its minimally invasive liquid biopsy tests for lung cancer.

Who else raised in Health Diagnostics and Biotechnology around the same time

Companies in the same sectors as Oxford Cancer Analytics that raised within 45 days of this round, from Fundz verified event records.

  • Noah Labs raised $3.1M (Seed) on February 20, 2025.
  • C the Signs raised $8M (Funding Round) on January 31, 2025.
  • Diag-Nose.io raised $2M (Seed) on January 30, 2025.
  • Raidium raised $13M (Seed) on December 2, 2024.
  • Predictmedix AI raised $320K (Seed) on February 22, 2025.
  • Level Zero Health raised $6.9M (Pre-Seed) on February 19, 2025.

Who to call at Oxford Cancer Analytics, and when

A new round usually means Oxford Cancer Analytics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Oxford Cancer Analytics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Oxford Cancer Analytics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Oxford Cancer Analytics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Oxford Cancer Analytics

Location

Oxford, England, United Kingdom

About

Oxford Cancer Analytics Ltd (OXcan) is on a mission to enable curative cancer treatments through early detection. OXcan's machine learning platform enables minimally invasive and inexpensive cancer screening in high risk populations through analysing cancer materials shed into the blood. OXcan hopes to create a paradigm shift in screening and eventually replacing invasive tissue biopsy and expensive, complex imaging as the current standard of care. It is safer, cheaper, and detects cancers much earlier, when they are still curable.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Oxford Cancer Analytics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsPeter L., CEO and Co-Founder hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Oxford Cancer Analytics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Oxford Cancer Analytics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.